Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.

Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.

Item
http://www.wikidata.org/entity/Q34987170
Update in Lung Cancer 2014Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatmentMARCKS protein overexpression in inflammatory breast cancer.Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target."Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.MARCKS is marked in combating lung cancer growth and acquired resistance.HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value.Myristoylated alanine-rich C kinase substrate (MARCKS): a multirole signaling protein in cancers.Small Molecule T315 Promotes Casitas B-Lineage Lymphoma-Dependent Degradation of Epidermal Growth Factor Receptor via Y1045 Autophosphorylation.Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS.The Rules and Functions of Nucleocytoplasmic Shuttling Proteins.Prior Knowledge Driven Joint NMF Algorithm for ceRNA Co-Module Identification
P2860

Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.

Item
http://www.wikidata.org/entity/Q34987170
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting myristoylated alanin ...... and therapeutic implications.
@ast
Targeting myristoylated alanin ...... and therapeutic implications.
@en
Targeting myristoylated alanin ...... and therapeutic implications.
@nl
type
label
Targeting myristoylated alanin ...... and therapeutic implications.
@ast
Targeting myristoylated alanin ...... and therapeutic implications.
@en
Targeting myristoylated alanin ...... and therapeutic implications.
@nl
prefLabel
Targeting myristoylated alanin ...... and therapeutic implications.
@ast
Targeting myristoylated alanin ...... and therapeutic implications.
@en
Targeting myristoylated alanin ...... and therapeutic implications.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Targeting myristoylated alanin ...... and therapeutic implications.
@en
P2093
P2860
P304
P31
P356
10.1164/RCCM.201408-1505OC
P407
P433
P478
P577
P5875
P698
P921
P932